首页> Open forum infectious diseases> Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials.

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jason,Grebely

第一单位： The Kirby Institute, UNSW Sydney, Sydney, Australia.

作者： Jason,Grebely ^[1] ; Massimo,Puoti ^[2] ; Heiner,Wedemeyer ^[3] ; Curtis,Cooper ^[4] ; Mark S,Sulkowski ^[5] ; Graham R,Foster ^[6] ; Thomas,Berg ^[7] ; Erica,Villa ^[8] ; Federico,Rodriguez-Perez ^[9] ; David L,Wyles ^[10] ; Gretja,Schnell ^[11] ; Negar N,Alami ^[11] ; Zhenzhen,Zhang ^[11] ; Emily,Dumas ^[11] ; Gregory J,Dore ^[1]

作者单位： The Kirby Institute, UNSW Sydney, Sydney, Australia. ^[1] Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Milan, Italy. ^[2] Medizinische Hochschule Hannover, Hannover, Germany. ^[3] Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. ^[4] Viral Hepatitis Center, Johns Hopkins University, Baltimore, Maryland. ^[5] Queen Mary University of London and Barts Health NHS Trust, London, United Kingdom. ^[6] Universitätsklinikum Leipzig, Leipzig, Germany. ^[7] University of Modena and Reggio Emilia, Modena, Italy. ^[8] Gastroenterology Department, VA Caribbean Healthcare System, San Juan, Puerto Rico. ^[9] Infectious Diseases Division, Department of Medicine at Denver Health, Denver, Colorado. ^[10] AbbVie Inc., North Chicago, Illinois. ^[11]

关键词 PWID drug use hepatitis C virus opioid substitution therapy

DOI 10.1093/ofid/ofy248

PMID 30430131

发布时间 2024-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览37

Open forum infectious diseases

2018年5卷11期

ofy248页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览37

点击下载本期目录封面

Open forum infectious diseases

2018年5卷11期

ofy248页

检索历史清除

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials.

Open forum infectious diseases

相似文献

同项目论文

Open forum infectious diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials.

Open forum infectious diseases

相似文献

同项目论文

Open forum infectious diseases

相关期刊

检索历史清除